Qualifications and Experience

Dr. Predrag-Peter Ilich, a retired pharmaceutical executive with 40+ years at Wyeth/Pfizer, advises on regulatory strategies and clinical development. His expertise in FDA/EMA compliance and infectious disease therapeutics supports TRIZ Biopharma’s drug pipeline, including Albuvir and MoLRx, for grant and market success.